Skip to content
Screener

Foghorn Therapeutics FHTX Q4 2025 Annual earnings

Reported March 11, 2026 · Before market open

Revenue$9.2MMiss by $904.7K
EPS-$0.34Miss by $0.06
Revenue estimate$10.2M
EPS estimate-$0.28

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$7.1M
EPS estimate-$0.22

FAQ

When did Foghorn Therapeutics report Q4 2025 earnings?
Foghorn Therapeutics (FHTX) reported Q4 2025 earnings on March 11, 2026 before market open.
What were Foghorn Therapeutics's Q4 2025 revenue and EPS?
Foghorn Therapeutics reported revenue of $9.2M and eps of $-0.34 for Q4 2025.
Did Foghorn Therapeutics beat estimates in Q4 2025?
Revenue missed the consensus estimate of $10.2M by $904.7K. EPS missed the consensus estimate of $-0.28 by $0.06.
How did Foghorn Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 223.8% from $2.9M a year earlier and eps declined 13.3% from $-0.30.
Where can I find Foghorn Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-016805) and the 10-K periodic report (0001628280-26-016814) directly on SEC EDGAR. The filing index links above go to sec.gov.